The putative anti-addictive drug ibogaine is a competitive inhibitor of [3H]MK-801 binding to the NMDA receptor complex

Piotr Popik, Richard T. Layer, Phil Skolnick

Psychopharmacology May 1, 1994 Peer reviewed DOI: 10.1007/bf02245000 via OpenAlex

Relevant Not relevant

Abstract

No abstract available from the source.

Tags

Nmda receptor Pharmacology Stimulant Addiction Sensitization

Involvement of NMDA glutamate receptors in the acquisition and reinstatement of the conditioned place preference induced by MDMA Behavioural Pharmacology • May 14, 2015 • via OpenAlex
Lysergic acid diethylamide and [−]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex Brain Research • August 27, 2004 • via OpenAlex
BDNF Release Is Required for the Behavioral Actions of Ketamine The International Journal of Neuropsychopharmacology • October 31, 2014 • via OpenAlex
Ibogaine attenuation of morphine withdrawal in mice: role of glutamate N-methyl-d-aspartate receptors Progress in Neuro-Psychopharmacology and Biological Psychiatry • June 21, 2003 • via OpenAlex
Chapter 3 Ibogaine as a glutamate antagonist: Relevance to its putative antiaddictive properties The Alkaloids. Chemistry and biology/The alkaloids. Chemistry and biology • January 1, 2001 • via OpenAlex

Comments

No comments yet.

Log in to comment